Company intelligence / Profile preview

Cytologic

Baltimore, Maryland, United States

Ownership: Private
Development stage: Other

Overview

CytoLogic is a biotechnology company focused on developing a high-precision platform for the isolation and characterization of rare cells from complex biological samples. The company's core technology utilizes microfluidics and advanced cell separation techniques to identify circulating tumor cells (CTCs) and other rare biomarkers for liquid biopsy applications. By enabling non-invasive diagnostic and monitoring tools, CytoLogic aims to improve early cancer detection and personalized treatment strategies. Additionally, the platform has potential applications in prenatal testing and the manufacturing of cell-based therapies.

Therapeutic areas: OncologyWomen's Health
Modalities: Cell therapyDiagnostics
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Cytologic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytologic.

Explore the full profile